Amneal Pharmaceuticals (AMRX) News Today $10.55 +0.13 (+1.25%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$10.51 -0.04 (-0.38%) As of 10/24/2025 04:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AMRX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Amneal Pharmaceuticals, Inc. (AMRX): A Bull Case TheoryOctober 21, 2025 | msn.comAmneal Pharmaceuticals, Inc. (AMRX): A Bull Case Theory October 21, 2025 | insidermonkey.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Given Average Rating of "Moderate Buy" by AnalystsOctober 16, 2025 | americanbankingnews.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives Average Rating of "Moderate Buy" from AnalystsOctober 11, 2025 | marketbeat.comThe Bull Case For Amneal Pharmaceuticals (AMRX) Could Change Following Biosimilar XOLAIR FDA Submission – Learn WhyOctober 9, 2025 | finance.yahoo.comA Look at Amneal Pharmaceuticals’s Valuation After XOLAIR Biosimilar Submissions and Recent Analyst UpgradesOctober 8, 2025 | finance.yahoo.comAmneal Pharmaceuticals (NASDAQ:AMRX) Receives Hold (C) Rating from Weiss RatingsOctober 8, 2025 | marketbeat.com3 Lesser-Known Healthcare Names With Major Upside in StoreThese are three healthcare stocks offering a compelling combination of secure business, strong fundamentals, and growth opportunity.October 2, 2025 | marketbeat.comAmneal Pharmaceuticals (NASDAQ:AMRX) Hits New 1-Year High - Should You Buy?October 1, 2025 | marketbeat.comAmneal Pharmaceuticals, Inc. (AMRX) Files BLA for XOLAIR® Biosimilar, Targets Multi-Billion-Dollar MarketOctober 1, 2025 | msn.comAmneal to Report Third Quarter 2025 Results on October 30, 2025September 30, 2025 | globenewswire.comAmneal Pharmaceuticals announces submission of BLA to U.S. FDA for XOLAIRSeptember 26, 2025 | msn.comAmneal Announces BLA Submission of Biosimilar Candidate to XOLAIR® (omalizumab)September 26, 2025 | globenewswire.comA Look at Amneal Pharmaceuticals's Valuation Following FDA Approval of Generic LUMIGANSeptember 24, 2025 | finance.yahoo.comAssenagon Asset Management S.A. Sells 70,885 Shares of AMNEAL PHARMACEUTICALS, INC. $AMRXSeptember 24, 2025 | marketbeat.comAmneal Pharma Stock Rises On FDA Approval For Generic Version Of AbbVie’s EyedropsSeptember 23, 2025 | msn.comAmneal Receives U.S. FDA Approval for Bimatoprost Ophthalmic Solution, 0.01%September 23, 2025 | globenewswire.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Given Average Recommendation of "Buy" by AnalystsSeptember 17, 2025 | marketbeat.comJPMorgan Chase & Co. Boosts Amneal Pharmaceuticals (NASDAQ:AMRX) Price Target to $14.00September 17, 2025 | marketbeat.comAmneal Pharmaceuticals price target raised to $14 from $12 at JPMorganSeptember 16, 2025 | msn.comGoldman Sachs Group Inc. Has $7.85 Million Stock Position in Amneal Pharmaceuticals, Inc. $AMRXSeptember 16, 2025 | marketbeat.comCaxton Associates LLP Takes Position in Amneal Pharmaceuticals, Inc. $AMRXSeptember 15, 2025 | marketbeat.comAQR Capital Management LLC Grows Stock Holdings in AMNEAL PHARMACEUTICALS, INC. $AMRXSeptember 15, 2025 | marketbeat.comAmneal Pharmaceuticals, Inc. $AMRX Stock Holdings Lifted by Acadian Asset Management LLCSeptember 14, 2025 | marketbeat.comWoodline Partners LP Grows Stock Position in Amneal Pharmaceuticals, Inc. $AMRXSeptember 14, 2025 | marketbeat.comJones Financial Companies Lllp Invests $1.73 Million in AMNEAL PHARMACEUTICALS, INC. $AMRXSeptember 14, 2025 | marketbeat.comAmneal wins FDA nod for generic targeting Jazz Pharma’s XyremSeptember 11, 2025 | msn.comWhy Amneal (AMRX) Stock Is Up TodaySeptember 11, 2025 | msn.comAmneal Pharmaceuticals: A Large, Diversified Clinical Portfolio That Keeps GrowingSeptember 11, 2025 | seekingalpha.comAmneal Receives U.S. FDA Approval of Sodium Oxybate Oral SolutionSeptember 11, 2025 | globenewswire.comAMNEAL PHARMACEUTICALS (NASDAQ:AMRX) Sets New 12-Month High - Here's WhySeptember 10, 2025 | marketbeat.comIeq Capital LLC Buys Shares of 34,327 AMNEAL PHARMACEUTICALS, INC. $AMRXSeptember 8, 2025 | marketbeat.comRaymond James Financial Inc. Has $5 Million Stock Position in AMNEAL PHARMACEUTICALS, INC. $AMRXSeptember 7, 2025 | marketbeat.comCubist Systematic Strategies LLC Takes $5.73 Million Position in Amneal Pharmaceuticals, Inc. $AMRXSeptember 6, 2025 | marketbeat.comNorthern Trust Corp Has $14.32 Million Position in AMNEAL PHARMACEUTICALS, INC. $AMRXSeptember 6, 2025 | marketbeat.comDark Forest Capital Management LP Has $4.19 Million Holdings in Amneal Pharmaceuticals, Inc. $AMRXSeptember 5, 2025 | marketbeat.comPDT Partners LLC Purchases 158,900 Shares of Amneal Pharmaceuticals, Inc. $AMRXSeptember 5, 2025 | marketbeat.comAmneal Pharmaceuticals, Inc.: Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable SuspensionSeptember 5, 2025 | finanznachrichten.deAmneal gets FDA approval for risperidone extended-release injectable suspensionSeptember 4, 2025 | msn.comAmneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable SuspensionSeptember 4, 2025 | globenewswire.comAmneal Pharmaceuticals, Inc. $AMRX Shares Purchased by Nantahala Capital Management LLCSeptember 3, 2025 | marketbeat.comTrexquant Investment LP Boosts Stock Holdings in AMNEAL PHARMACEUTICALS, INC. $AMRXSeptember 3, 2025 | marketbeat.comHsbc Holdings PLC Purchases 26,651 Shares of AMNEAL PHARMACEUTICALS, INC. $AMRXSeptember 2, 2025 | marketbeat.comState of Wyoming Has $685,000 Stock Holdings in AMNEAL PHARMACEUTICALS, INC. $AMRXSeptember 1, 2025 | marketbeat.comJump Financial LLC Boosts Holdings in AMNEAL PHARMACEUTICALS, INC. $AMRXAugust 30, 2025 | marketbeat.comJohn Kiely Sells 32,000 Shares of Amneal Pharmaceuticals (NASDAQ:AMRX) StockAugust 29, 2025 | insidertrades.comWalleye Capital LLC Buys 519,863 Shares of AMNEAL PHARMACEUTICALS, INC. $AMRXAugust 29, 2025 | marketbeat.comAmneal Pharmaceuticals (NASDAQ:AMRX) EVP Sells $60,230.00 in StockAugust 27, 2025 | marketbeat.comAmneal Pharmaceuticals (NASDAQ:AMRX) EVP Sells $1,105,992.72 in StockAugust 27, 2025 | marketbeat.comVirtus Advisers LLC Takes Position in Amneal Pharmaceuticals, Inc. $AMRXAugust 27, 2025 | marketbeat.com Get Amneal Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AMRX Media Mentions By Week AMRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMRX News Sentiment▼0.520.93▲Average Medical News Sentiment AMRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMRX Articles This Week▼46▲AMRX Articles Average Week Get the Latest News and Ratings for AMRX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Amneal Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies RDY News Today VTRS News Today ROIV News Today QGEN News Today ELAN News Today BBIO News Today MRNA News Today RVMD News Today VRNA News Today RYTM News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMRX) was last updated on 10/25/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amneal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amneal Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
